“Сoronavirus syndromе”: prevention of phsychotrauma caused by COVID-19

N.V. Solovieva¹, E.V. Makarova^1,2, I.V. Kichuk³

¹Personilized Psychiatry JSC, Moscow

²National Medical Research Center of Rehabilitation and Resort Medicine, Moscow

³Pirogov Russian National Research Medical University, Moscow

COVID-19 (COronaVIrus Disease 2019) is a new viral infection characterized by rapid spread, high mortality rate, significant social and economic consequences that destroy the usual way of life. Coronavirus syndrome is a mental disorder presenting itself a response to the COVID-19 pandemic. Presumably, the coronavirus syndrome will affect up to 10% of the population involved in the pandemic, mainly people who have been exposed to a combination of psychosocial and biological factors of stress vulnerability. The article discusses predisposing factors and clinical manifestations of coronavirus syndrome. The risk groups of developing coronavirus syndrome are medical workers who provide care to patients with COVID-19; patients who have suffered a severe disease form, lost relatives and friends, as well as those who have suffered extensive financial losses and lost their jobs. The authors consider treatment methods for coronavirus syndrome: psychotherapy (cognitive behavioural therapy with narrative and exposure methods) and pharmacotherapy, which should be aimed at relieving anxiety, restoring sleep, treating depression and other mental disorders. The a uthors also emphasize that timely psychotherapy and pharmacotherapy of the coronavirus syndrome is very important since it is assumed that this syndrome will reduce the work productivity of the population at a time when it will be extremely necessary for economic recovery.

Keywords: COVID-19, post-traumatic stress disorder, psychotherapy, pharmacotherapy, fabomotizol, anxiolytic.

For citation: Solovieva N.V., Makarova E.V., Kichuk I.V. “Coronavirus syndromе”: prevention of phsychotrauma caused by COVID-19. RMJ. 2020;9:18–22.